| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | -19.727 | -17.213 | -11.924 | 13.738 | 13.567 | 12.559 | 18.925 | 11.868 | 2.157 | 714 |
| Gross Profit/Loss - EUR | 19.727 | 17.213 | 11.924 | -13.738 | -13.567 | -12.559 | -18.925 | -11.868 | -2.157 | -714 |
| Net Profit/Loss - EUR | 18.861 | 16.391 | 11.259 | -13.738 | -13.567 | -12.559 | -18.925 | -11.868 | -2.157 | -714 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ageneva Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 70.233 | 59.703 | 49.044 | 39.235 | 29.112 | 19.375 | 9.964 | 986 | 168 | 95 |
| Current Assets | 58 | 15 | 1 | 3 | 16 | 4 | 1 | 2 | 50 | 27 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 58 | 15 | 1 | 3 | 16 | 4 | 1 | 2 | 50 | 27 |
| Shareholders Funds | 18.652 | 34.852 | 45.522 | 30.948 | 16.782 | 3.904 | -15.107 | -27.022 | -29.098 | -29.649 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 51.639 | 24.865 | 5.119 | 15.116 | 20.694 | 23.663 | 25.072 | 28.009 | 29.315 | 29.771 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ageneva Medical Srl